izvor podataka: crosbi
!
Combination of capecitabine and mitomycin C as first-line treatment in patients with metastatic breast cancer (CROSBI ID 699690)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa
Vrdoljak E., Boban M., Omrcen T., Hrepić D., Fridl-Vidas V., Boskovic L.
Combination of capecitabine and mitomycin C as first-line treatment in patients with metastatic breast cancer // Neoplasma 58. 2011. str. 172-178
Podaci o odgovornosti
Vrdoljak E., Boban M., Omrcen T., Hrepić D., Fridl-Vidas V., Boskovic L.
engleski
Combination of capecitabine and mitomycin C as first-line treatment in patients with metastatic breast cancer
This is an open-label, non-comparative efficacy and safety study of Capecitabine and Mitomycin C as first-line treatment in patients with previously untreated metastatic breast cancer.
capecitabine, mitomycin, metastatic breast cancer
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
172-178.
2011.
objavljeno
Podaci o matičnoj publikaciji
Neoplasma 58
Podaci o skupu
Neoplasma 58
poster
01.01.2011-01.01.2011
Hrvatska
